ConductScience.org, home

Paper718154

SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.

Tsuchiya K and 5 others. Antimicrob Agents Chemother, 1978. Cited by 31 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Papers, record 718154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/718154

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2021-05-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsuchiya KK
2Kida MM
3Kondo MM
4Ono HH
5Takeuchi MM
6Nishi TT

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CephalosporinsMajor topic
Animals
Bacterial Infections
Culture Media
Dose-Response Relationship, Drug
Drug Resistance, Microbial
Male
Mice
Mice, Inbred ICR
Microbial Sensitivity Tests

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,742,934Microbiological studies on a new broad-spectrum penicilin, "Penbritin".Br Med J1961https://conductscience.org/library/papers/13742934PubMed
2417,670SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/417670PubMed
3337,891Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/337891PubMed
4249,623Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/249623PubMed
54,586,142Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4586142PubMed
6170,856Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/170856PubMed
7950,320CGP 9000: a new orally active, broad-spectrum cephalosporin.J Antibiot (Tokyo)1976https://conductscience.org/library/papers/950320PubMed
81,259,407Cefuroxime, a new cephalosporin antibiotic: activity in vitro.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259407PubMed

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
8,787,916Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787916PubMed
7,004,342Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7004342PubMed
7,004,338Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7004338PubMed
6,999,983Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6999983PubMed
6,994,642GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6994642PubMed
6,969,578Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6969578PubMed
6,968,539Purification and properties of a new beta-lactamase from Pseudomonas cepacia.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6968539PubMed
6,967,295Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6967295PubMed
6,941,742Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6941742PubMed
6,446,879Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6446879PubMed
6,331,302Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6331302PubMed
6,297,387Pharmacokinetics of cefotiam in normal humans.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6297387PubMed
6,293,976The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.Infection1982https://conductscience.org/library/papers/6293976PubMed
6,271,094Nephrotoxicity of cefotiam (CGP 14221/E) in rats and rabbits.Arch Toxicol1981https://conductscience.org/library/papers/6271094PubMed
6,271,051In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6271051PubMed
6,269,488Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6269488PubMed
6,251,749In vitro antimicrobial activity of cefotaxime, a new cephalosporin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6251749PubMed
6,097,166Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6097166PubMed
3,865,632Cefotiam therapy of lower respiratory tract infections.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3865632PubMed
3,857,018Pharmacokinetics of cefotiam in humans.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3857018PubMed

See all 23 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/718154

GET https://conductscience.org/api/papers/v1/718154/cited_by?page=2